45525 (CUR.TO) Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average Volume130,253 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive CUR News and Ratings via Email

Sign-up to receive the latest news and ratings for 45525 (CUR.TO) and its competitors with MarketBeat's FREE daily newsletter.

About 45525 (CUR.TO)

9342-8530 Quebec Inc, formerly Diagnocure Inc, is a Canada-based biotechnology company. The Company specializes in the development and commercialization of products relating to the diagnosis of cancer. It intends to focus its activities on business development efforts by out-licensing, selling or partnering with third parties with regards to its Previstage GCC and its new multimarker prostate cancer test (PCP). The Company's colorectal cancer staging test, Previstage GCC, uses the Guanylyl Cyclase C (GCC or GUCY2C) marker to stratify the risk of colon cancer recurrence by determining the stage of the disease. Previstage GCC Colorectal Cancer Staging test is a molecular test for the staging of colorectal cancer patients. The PROGENSA PCA3 assay is a molecular urine test that can be used as a predictor of biopsy outcome in men with a serum prostate specific antigen (PSA) level over 2.5 nanograms per milliliter (ng/ml).


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

45525 (CUR.TO) (TSE:CUR) Frequently Asked Questions

What stocks does MarketBeat like better than 45525 (CUR.TO)?

Wall Street analysts have given 45525 (CUR.TO) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 45525 (CUR.TO) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are some of 45525 (CUR.TO)'s key competitors?

What other stocks do shareholders of 45525 (CUR.TO) own?

What is 45525 (CUR.TO)'s stock symbol?

45525 (CUR.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CUR."

How do I buy shares of 45525 (CUR.TO)?

Shares of CUR and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How many employees does 45525 (CUR.TO) have?

45525 (CUR.TO) employs 6 workers across the globe.

What is 45525 (CUR.TO)'s official website?

The official website for 45525 (CUR.TO) is www.neuralstem.com.

Where are 45525 (CUR.TO)'s headquarters?

45525 (CUR.TO) is headquartered at 250-4535 Wilfrid-Hamel Blvd, QUEBEC, QC G1P 2J7, Canada.

How can I contact 45525 (CUR.TO)?

45525 (CUR.TO)'s mailing address is 250-4535 Wilfrid-Hamel Blvd, QUEBEC, QC G1P 2J7, Canada. The biotechnology company can be reached via phone at +1-418-5276100.

This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.